Recent studies on Down syndrome fibroblasts, using pharmacological inhibition of CBS, as well as genetic silencing of CBS, indicated that the metabolic inhibition seen in Down syndrome cells, is at least, in part, caused by the overproduction of H2S by CBS [9]. This evidence concerns the gene CBS and Down syndrome.